Risk stratification in decisions about nonsteroidal anti-inflammatory drug cotherapy.
Successful application of risk stratification in decisions about nonsteroidal anti-inflammatory drug (NSAID) therapy could enable patients with a lower baseline risk of gastrointestinal (GI) complications to take a nonspecific generic NSAID and those with greater risk of GI complications to take the cotherapies.